Sanjay Chandru Keswani insider trades
Open-market stock purchases and sales by Sanjay Chandru Keswani, Chief Medical Officer at Neurocrine Biosciences Inc, from SEC Form 4 filings since Jun 2, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 11, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Sep 11, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $330K |
| Jun 2, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $268K |
| Jun 2, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
Companies traded
- NBIX Neurocrine Biosciences Inc: other filings, last Sep 11, 2026
Get free alerts when Sanjay Chandru Keswani files a new trade →